According to the brand, each serving delivers 30 billion AFU (Active Fluorescent Units), a significantly higher dose than many comparable supplements on the market
Who Is Generally Excluded FDA labels list contraindications and precautions that typically rule out or require caution with GLP-1 therapy: Personal or family history of medullary thyroid carcinoma Multiple endocrine neoplasia syndrome type 2 (MEN 2) Known hypersensitivity to the drug History of pancreatitis (caution, not absolute contraindication) Active gallbladder disease (caution) Severe gastroparesis or other significant GI motility disorders Pregnancy or planning pregnancy (discontinuation typically recommended) Type 1 diabetes (not studied for this indication) Additionally, patients with severe kidney or liver disease, those on certain medications that affect insulin or GI motility, and those with eating disorders should have careful evaluation
It works by stimulating insulin secretion after a meal, reducing glucagon secretion, delaying gastric emptying, causing a reduction in hunger and food intake, slowing the release of food from the stomach, and increasing feelings of fullness after eating(2 Trusted Source Weight Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide-1 Receptor Agonists Go to source)
As you eat less, your body uses stored energy
